MEDIAN TECHNOLOGIES
Median Technologies is a French société anonyme (SA) registered under SIREN 443 676 309 (SIRET 443 676 309 00042), incorporated on 1 October 2002 and recorded in France’s business register maintained by INSEE and the Institut National de la Propriété Industrielle (INPI). Its registered office is at Les Deux Arcs, 1800 Route des Crêtes, 06560 Valbonne, in the Sophia Antipolis technology park in southeastern France. The company develops artificial intelligence, computer-vision and signal-processing technologies that convert medical images into quantitative imaging biomarkers for oncology, operating through two divisions: iCRO (Imaging Contract Research Organization), which provides medical-image analysis and management services to biopharmaceutical companies running oncology clinical trials, and eyonis, a suite of AI/machine-learning software-as-a-medical-device products for precision diagnostics, including the eyonis LCS lung-cancer-screening product. As of early 2026 the company reported supporting more than 220 clinical studies, including over 70 Phase 3 oncology trials, for biopharmaceutical sponsors. Median Technologies shares have traded on Euronext Growth Paris since the company’s 2013 initial public offering, under ISIN FR0011049824 and ticker ALMDT. For the financial year ended 31 December 2025, the company reported consolidated revenue of 23.4 million euros, up 1.7% from 22.9 million euros in 2024, with group operations in France, the United States (Boston, Massachusetts) and China (Shanghai) and over 230 employees as of 2026. In August 2025 and June 2026 the company completed successive capital increases of approximately 23.9 million euros and up to 50 million euros respectively, stated as funding the commercial deployment of eyonis LCS in the United States and Europe and further clinical indications for its imaging-biomarker technology. Registration as active on the French business register does not by itself confirm current trading activity.
- Company fundamentals
- Corporate linkage & group structures
- Digitized company financials
- Firmographics — websites, social profiles, revenue and employee estimates
Shareholders
1
Shareholders of Median Technologies
Median Technologies is listed on Euronext Growth Paris, a market segment where public disclosure generally covers only shareholders above defined notification thresholds rather than a complete share register. According to the shareholding structure published on the company’s investor relations website as of 5 June 2026, total share capital comprised 48,682,387 shares held as follows: Ann-Helene & Fredrik Ljungström, 10.7%; Katarina Martinson AB, 8.9%; Celestial Successor Fund, 5.2%; Matignon Finance, 3.3%; a holding the company labels “Venture”, 3.1%; Furui Medical Science Company, 3.1%; and Lion Point LP, 3.1%. The remaining 62.6% of share capital was held in free float. An entity related to Lion Point Capital, whose founding partner Didric Cederholm joined Median Technologies’ board of directors on 30 October 2025, entered the shareholder base during 2025.
Median Technologies’ founder and Chief Executive Officer, Fredrik Brag, does not appear among the named holdings in this disclosed table as of the June 2026 disclosure date; this profile does not assume or estimate a shareholding for him or for any other individual not named in the disclosed table.
Ultimate beneficial ownership
No authoritative source reviewed identifies an individual as a beneficial owner of Median Technologies, and no complete ownership chain is available to calculate an effective indirect percentage for any of the corporate or family holdings listed above. No ultimate beneficial owner is therefore reported.
Data availability
Shareholder disclosure for Median Technologies is classified as Major shareholders only: holdings above the applicable notification thresholds are published together with an aggregate free-float figure, but a complete shareholder register is not publicly available for this Euronext Growth-listed company.
Sources
- Median Technologies, Investors – shareholding structure, mediantechnologies.com/investors, data as of 5 June 2026, retrieved 18 September 2026
- Median Technologies press release, “Median Technologies Appoints Didric Cederholm to Its Board of Directors”, businesswire.com, 3 November 2025
- Autorité des Marchés Financiers (AMF), major-shareholding disclosure regime for Euronext Growth issuers
Registry feed — rows exactly as filed with INPI (Institut National de la Propriété Industrielle), including entries the profile above does not cover.
| Shareholder | Type | Holding | Source Document |
|---|---|---|---|
| Oran Muduroglu | INPI (Institut National de la Propriété Industrielle) |
Officers
38
Directors and officers of Median Technologies
Median Technologies is a société anonyme governed by a board of directors (conseil d’administration). Based on the company’s official website and 2025–2026 shareholder-meeting disclosures, the board comprised seven directors: Oran Muduroglu (Chairman), Fredrik Brag (founder and Chief Executive Officer), Tim Haines (affiliated with Abingworth), Kapil Dhingra, Oern Stuge, Ben McDonald (affiliated with Aegis Group Partners) and Didric Cederholm (affiliated with Lion Point Life Sciences Partners). The executive management team, distinct from the board, includes Jean-Christophe Montigny (Chief Financial Officer), Nicolas Dano (Chief Operating Officer and Chief Commercial Officer, iCRO), Thomas Bonnefont (Chief Operating Officer and Chief Commercial Officer, eyonis) and Chrystel Brun (Chief Human Resource Officer). Individual appointment dates, occupations, nationality and country of residence are not disclosed in the sources reviewed for most board members and executives; in line with this profile’s sourcing rules, these are reported as not disclosed rather than inferred from names or professional affiliations.
Recent officer changes
- Didric Cederholm (Lion Point Life Sciences Partners) was appointed to the board of directors at the ordinary general meeting of 30 October 2025 (source: company press release, 3 November 2025).
- Oran Muduroglu, Chairman of the board, was also named President of Median eyonis Inc., the company’s United States subsidiary responsible for commercial deployment of eyonis LCS, in a February 2026 company announcement.
Data availability
Officer information for Median Technologies is classified as Partial: current board composition and senior executive titles are published on the company’s official website and in shareholder-meeting materials, but appointment and resignation dates, occupations, nationality and country of residence are not comprehensively disclosed for every individual in the sources reviewed.
Sources
- Median Technologies, About us – leadership, mediantechnologies.com/about-us, retrieved 18 September 2026
- Median Technologies press release, “Median Technologies Appoints Didric Cederholm to Its Board of Directors”, businesswire.com, 3 November 2025
- Median Technologies company announcement on Oran Muduroglu’s appointment as President of Median eyonis Inc., February 2026
Registry feed — rows exactly as filed with INPI (Institut National de la Propriété Industrielle), including entries the profile above does not cover.
Group Structure
Group structure of Median Technologies
Median Technologies SA is the publicly listed parent company of its group; no immediate or ultimate parent company above Median Technologies SA was identified in the sources reviewed. Based on the management report of the board of directors for the financial year ended 31 December 2025, the group’s consolidation scope includes at least two verified subsidiaries alongside the French parent: Median Technologies Inc. in the United States, which operates under a cost-plus intercompany services contract dating from 2014 and reported FY2025 revenue of approximately $2,268 thousand (about €2,009 thousand), and Median Medical Technology (Shanghai) Co., Ltd in China, which reported approximately 51 employees as of 31 December 2025 and FY2025 revenue of approximately RMB 73,401 thousand (about €9,046 thousand). A further United States entity, Median eyonis Inc., was referenced in a February 2026 company announcement as the vehicle for commercial deployment of the eyonis LCS product in the United States, with board chairman Oran Muduroglu named as its President. Ownership percentages for these subsidiaries were not disclosed in the sources reviewed and are not assumed to be 100%.
Verified corporate relationships
| Entity | Country | Registration number | Relationship | Ownership | Status | Information date |
|---|---|---|---|---|---|---|
| Median Technologies Inc. | United States | Not disclosed | Direct subsidiary | Ownership percentage not disclosed | Active | FY2025 (year ended 31 Dec 2025) |
| Median Medical Technology (Shanghai) Co., Ltd | China | Not disclosed | Direct subsidiary | Ownership percentage not disclosed | Active | FY2025 (year ended 31 Dec 2025) |
| Median eyonis Inc. | United States | Not disclosed | Possible relationship (referenced as US commercial subsidiary) | Ownership percentage not disclosed | Active | February 2026 |
Recent structural changes
- Median eyonis Inc. was presented as the company’s dedicated United States commercialization subsidiary for eyonis LCS, with Oran Muduroglu named as its President in February 2026.
Data availability
Corporate-linkage information for Median Technologies is classified as Partial: the existence of United States and Chinese subsidiaries is confirmed through the management report and company announcements, but registration numbers, incorporation dates and precise ownership percentages for these entities were not disclosed in the sources reviewed.
Sources
- Median Technologies, Management Report of the Board of Directors – financial year ended 31 December 2025 (OGM/EGM 10 June 2026)
- Median Technologies, About us, mediantechnologies.com/about-us, retrieved 18 September 2026
- Median Technologies company announcement on Oran Muduroglu’s appointment as President of Median eyonis Inc., February 2026
MEDIAN TECHNOLOGIES
France
Get complete shareholder and officer records, ultimate beneficial owner resolution, and ongoing ownership monitoring.
Frequently Asked Questions
What is the legal name and legal form of the company registered under SIREN 443676309?
The company is Median Technologies, a French société anonyme (SA) governed by a board of directors.
What is Median Technologies' SIREN and SIRET registration number?
Its SIREN is 443 676 309 and the SIRET of its registered establishment is 443 676 309 00042 (on file as registration number 44367630900042).
When was Median Technologies incorporated?
Median Technologies was incorporated on 1 October 2002, according to France's business register.
Where is Median Technologies registered and headquartered?
Its registered office is at Les Deux Arcs, 1800 Route des Crêtes, 06560 Valbonne, France, in the Sophia Antipolis technology park.
In which country is Median Technologies incorporated?
Median Technologies is incorporated in France (country code FR).
What is Median Technologies' current registration status?
Median Technologies is recorded as active on France's business register as of the most recent listing reviewed. An active registration status does not by itself confirm current trading activity.
Is Median Technologies a publicly listed company?
Yes. Median Technologies shares trade on Euronext Growth Paris under ISIN FR0011049824 and ticker ALMDT.
What does Median Technologies do?
Median Technologies develops AI, computer-vision and signal-processing technologies that convert medical images into imaging biomarkers for oncology, through its iCRO imaging-services division and its eyonis AI/ML software-as-a-medical-device products, including the eyonis LCS lung-cancer-screening product.
Who is the Chief Executive Officer of Median Technologies?
Fredrik Brag, the company's founder, serves as Chief Executive Officer and sits on the board of directors.
Who chairs Median Technologies' board of directors?
Oran Muduroglu is Chairman of the board of directors.
Does Median Technologies have subsidiaries?
Yes. Disclosed subsidiaries include Median Technologies Inc. and Median eyonis Inc. in the United States and Median Medical Technology (Shanghai) Co., Ltd in China.
What was Median Technologies' revenue in its most recently reported financial year?
For the financial year ended 31 December 2025, Median Technologies reported consolidated revenue of 23.4 million euros, up 1.7% from 22.9 million euros in 2024.
Are Median Technologies' shareholders publicly disclosed?
Only major shareholders are disclosed, consistent with Euronext Growth's notification-threshold regime; as of 5 June 2026 the company reported 62.6% of its shares in free float.
Does Median Technologies have a company website?
Yes, its official website is mediantechnologies.com; the on-file website reference points to its legal-notice page.
How is Median Technologies' company data kept up to date on Zavia.ai?
Zavia.ai periodically reviews official company-registry, securities-market and regulatory-filing sources to refresh this Median Technologies profile, and this company's record can also be accessed through the Zavia.ai company data API.